Ajanta Pharma Limited has informed the Exchange about (Revised) Participation in Investor Conference
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma Limited has filed a revised schedule for upcoming analyst and institutional investor meetings. The company clarified that dates for two conferences were inadvertently interchanged in the previous filing and has now corrected them. The first meeting is scheduled for May 29, 2026 with 360 ONE Capital (B&K) at Grand Hyatt, Santacruz, and the second is on June 8, 2026 with ICICI Securities India. The company has confirmed that discussions during these meetings will be strictly based on already published information. This filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015.
This is a routine compliance disclosure with neutral impact on the stock. No new material information is expected from these meetings as discussions will be limited to publicly available information.